Skip to main content
BDX
NYSE Industrial Applications And Services

BD Recasts Historical Financials Post-Spin-Off for Continuing Operations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$154.51
Mkt Cap
$43.995B
52W Low
$127.536
52W High
$187.35
52W Position info
21% above low
Off High info
18% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BDX sits 21% above its 52-week low of $127.536.

Summary

Becton Dickinson provides recast historical financial data, presenting its spun-off business as discontinued operations to establish a clear financial baseline for its continuing business.


Key Events · Corporate Governance and Compliance · BDX

  • Recast Historical Financials

    Becton Dickinson furnished unaudited recast historical financial information, reflecting the Biosciences and Diagnostic Solutions business as discontinued operations.

  • Post-Spin-Off Baseline

    This re-presentation provides a historical baseline of BD's standalone operating results from continuing operations, excluding specified items, following the February 9, 2026 spin-off.

  • Non-GAAP Measures Included

    The furnished exhibit includes certain non-GAAP financial measures with adjustments for purchase accounting, integration, restructuring, transaction costs, and other items to aid in period-over-period comparability.


Analysis · BDX · Industrial Applications And Services

Becton Dickinson has filed recast historical financial information to reflect its Biosciences and Diagnostic Solutions business as discontinued operations following the spin-off on February 9, 2026. This filing is crucial for investors and analysts to establish a new financial baseline for BD's continuing operations, enabling accurate year-over-year comparisons and future performance analysis. It provides transparency into the company's standalone financial health post-separation.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDX was trading at $154.51 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $44B. The 52-week trading range was $127.54 to $187.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Nov 05, 2026, 6:54 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $206.00
Real-time Price: $218.03 info
Change: +$12.03 (+6%) info
Market Cap: $59.388B info
BDX
Nov 05, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $204.07
Real-time Price: $218.03 info
Change: +$13.96 (+7%) info
Market Cap: $59.388B info
BDX
Nov 05, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $205.50
Real-time Price: $218.03 info
Change: +$12.53 (+6%) info
Market Cap: $59.388B info
BDX
Oct 07, 2026, 1:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $181.41
Real-time Price: $218.03 info
Change: +$36.63 (+20%) info
Market Cap: $59.388B info
BDX
Oct 07, 2026, 8:20 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $177.43
Real-time Price: $218.03 info
Change: +$40.60 (+23%) info
Market Cap: $59.388B info